News | August 18, 2011

U-Systems Receives Health Canada Approval For Ultrasound Breast Cancer Screening

U-Systems Receives Health Canada Approval For  Ultrasound Breast Cancer Screening

August 18, 2011 U-Systems announced that it has been granted a medical device license by the Medical Devices Bureau of Health Canada to sell and market the somo•v automated breast ultrasound (ABUS) system as an adjunct to mammography for screening asymptomatic women for breast cancer in Canada.  Approval was based on extensive clinical evidence and includes the following indication: “The somo•v ABUS ultrasound device is intended for use as an adjunct to mammography to provide physicians with an increase in the sensitivity of breast cancer detection in diagnostic symptomatic and screening asymptomatic women.”  

The somo•v ABUS system is the only ultrasound device approved for breast cancer screening by Health Canada, the agency responsible for assessing medical device safety, effectiveness and quality  in Canada.  The somo•v ABUS system is also the only ultrasound device approved for breast cancer screening in the 27 European Union countries. In the United States, the somo•v ABUS system is cleared by the Food & Drug Administration (FDA) for adjunctive diagnostic use with mammography.

“With this approval from Health Canada, we are proud to make this critical screening tool available to improve the early detection of breast cancer in Canada,” said Ron Ho, president and CEO of U-Systems.  “The somo•v Automated Breast Ultrasound System is not intended as a replacement for mammography.  However, there is a growing body of scientific evidence that supplementing mammography with ultrasound detects more cancers than mammography alone.”

Using proprietary technology to automate the breast ultrasound imaging process, the U-Systems’ somo•v ABUS is ideally suited for the high-volume, screening environment.  The somo•viewer Advanced 3-D Workstation enables fast review and archive of patient exams, optimizing breast ultrasound screening workflow.

U-Systems is also the sponsor of the national SOMO•INSIGHT Clinical Study, which is designed to evaluate whether digital mammography in combination with somo•v ABUS is more sensitive than a routine screening mammogram alone in detecting breast cancer in women with dense breast tissue. More than 15,000 women have participated in the study, which is actively recruiting up to 20,000 women at multiple breast imaging centers nationwide. To date, the study has identified a significant number of mammographically negative breast cancers that were subsequently detected by ABUS.

For more information: www.u-systems.com

 

Related Content

According to the CDC, if you are fully vaccinated you can start doing many things that you had stopped doing because of the pandemic. Infographic courtesy of the CDC.

According to the CDC, if you are fully vaccinated you can start doing many things that you had stopped doing because of the pandemic. Infographic courtesy of the CDC.

News | Coronavirus (COVID-19) | May 13, 2021
May 13, 2021 — The Centers for Disease Control and Prevention (CDC) just
National Imaging Solutions, a recognized leader in medical imaging and radiology solutions, announced it has acquired DynaRad — the oldest manufacturer of portable X-ray systems in the US. This new investment will allow National Imaging Solutions to support its customers by supplying them with DynaRad portable X-ray machines, including a mobile field X-ray device using nanotube technology.
News | Radiology Business | May 11, 2021
May 11, 2021 — ...
New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

News | Artificial Intelligence | May 07, 2021
The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

News | Breast Imaging | April 23, 2021
April 23, 2021 — The U.S.
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Videos | Point-of-Care Ultrasound (POCUS) | April 01, 2021
Here are two quick clinical examples of point-of-care ultrasound (POCUS) lung imaging and cardiac imaging using a GE
ScImage, Inc. celebrates its cloud partnership with Digirad Health (“Digirad”), a division of Star Equity Holdings, after a year of successful deployment of PICOM365 for mobile imaging. Digirad’s fleet of mobile SPECT, echocardiology, vascular and general ultrasound units combined with PICOM365’s cloud image management workflow leverage each company’s strengths to create an exemplary reading and reporting environment.
News | Archive Cloud Storage | March 30, 2021
March 30, 2021 — ScImage, Inc.
The 3D image of the collapsing virus, right, captured at the instant of the maximum vibration amplitude. Spikes were removed from the color-coded plot, on left, for clarity. Image courtesy of the researchers

The 3D image of the collapsing virus, right, captured at the instant of the maximum vibration amplitude. Spikes were removed from the color-coded plot, on left, for clarity. Image courtesy of the researchers

News | Coronavirus (COVID-19) | March 18, 2021
March 18, 2021 — The coronavirus' structure is a